Clinical Evaluation of Unani Formulation in the Management of Wajaul Mufasil (Osteo-Arthritis) - A Randomized, Single Blind Clinical Trial

Wajaul Mufasil (Osteo-arthritis = joint pain with inflammation) especially for knee Joint. Arthritis is very common; it is an inflammation of the joint. It can affect one joint or multiple joints. It’s a chronic progressive degenerative joint disease affecting mainly the articular cartilage of the beg weight bearing joints of the body. There are more than 100 different types of arthritis, with different causes and treatment methods. The first known traces of human arthritis date back as far as 4500 BC. It is seen in Italy and Austria. Around 30-50 % of the world’s population experiences OA for knee joint pain at some time in their lives though; the pain is short lived and responds to symptomatic measures. Unani formulation as Ajwain (Trachyspermum ammi), Haloon (Lepidium sativum), Kalonji (Nigella sativa) and Methi (Trigonella foenum graecum) is one of the oldest treatments of Unani practiced by Unani physician. It is used generally as a powder form with oral administration. This formulation effect as analgesic, anti-inflammatory, antimicrobials and immuno-modulator, Interventions were given in a total of 60 patients for 30 days. Was administered Unani formulation only. The objective of the study is to evaluate the efficacy of Unani formulation in the management of Wajaul Mufasil. The result indicated clinically significant.